Inventor
KESTER JEFFREY A
US14 patents
⚠️ This page may combine multiple inventors who share the name “KESTER JEFFREY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
9 patentsUS6162927ADec 19, 2000
Endothelin antagonists
ABBOTT LAB46 citations96
US5767144AJun 16, 1998
Endothelin antagonists
ABBOTT LAB90 citations96
US5250548AOct 5, 1993
Angiotensin II receptor antagonists
ABBOTT LAB57 citations95
US7365093B2Apr 29, 2008
Endothelin antagonists
ABBOTT LAB18 citations92
US6946481B1Sep 20, 2005
Endothelin antagonists
ABBOTT LAB37 citations92
US6462194B1Oct 8, 2002
Endothelin antagonists
ABBOTT LAB14 citations92
US5622971AApr 22, 1997
Endothelin antagonists
ABBOTT LAB25 citations92
US6380241B1Apr 30, 2002
Treatment of diseases using endothelin antagonists
ABBOTT LAB13 citations82
US5731434AMar 24, 1998
Endothelin antagonists
ABBOTT LAB15 citations82
WARNER LAMBERT CO
4 patentsUS4999430AMar 12, 1991
Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine
WARNER LAMBERT CO6 citations73
US4996201AFeb 26, 1991
4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents
WARNER LAMBERT CO8 citations73
US4855308AAug 8, 1989
Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents
WARNER LAMBERT CO17 citations73
US4988688AJan 29, 1991
4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents
WARNER LAMBERT CO2 citations62